Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Kalayjian

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Infectious Disease Reports|December 23, 2011
Kidney Disease in HIV-Infected PersonsRobert C Kalayjian
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2014
Editorial commentary: Cystatin C and statins in HIV diseaseRobert C Kalayjian
Advances in Chronic Kidney Disease|December 17, 2009
The treatment of HIV-associated nephropathyRobert C Kalayjian
Current HIV/AIDS Reports|June 7, 2011
Renal issues in HIV infectionRobert C Kalayjian
Infectious Disease Clinics of North America|September 17, 2017
Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral TherapyPuja Van Epps, Robert C Kalayjian
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2019
Bisphosphonates in Perinatally Infected Children and Adolescents With Human Immunodeficiency Virus: Targeting PubertyRobert C Kalayjian, Grace A McComsey
Current Infectious Disease Reports|October 28, 2009
HIV and the KidneyLeslie A Bruggeman, Charles Bark, Robert C Kalayjian
Antiviral Therapy|July 7, 2009
The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy eraSamir K Gupta, Marlene Smurzynski, Nora Franceschini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 15, 2014
Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsRobert C Kalayjian, Kunling Wu, Scott Evans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 3, 2019
Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated IndividualsRobert C Kalayjian, Kevin R Robertson, Jeffrey M Albert, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Infectious Disease Reports|December 23, 2011
Kidney Disease in HIV-Infected PersonsRobert C Kalayjian
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2014
Editorial commentary: Cystatin C and statins in HIV diseaseRobert C Kalayjian
Advances in Chronic Kidney Disease|December 17, 2009
The treatment of HIV-associated nephropathyRobert C Kalayjian
Current HIV/AIDS Reports|June 7, 2011
Renal issues in HIV infectionRobert C Kalayjian
Infectious Disease Clinics of North America|September 17, 2017
Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral TherapyPuja Van Epps, Robert C Kalayjian
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2019
Bisphosphonates in Perinatally Infected Children and Adolescents With Human Immunodeficiency Virus: Targeting PubertyRobert C Kalayjian, Grace A McComsey
Current Infectious Disease Reports|October 28, 2009
HIV and the KidneyLeslie A Bruggeman, Charles Bark, Robert C Kalayjian
Antiviral Therapy|July 7, 2009
The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy eraSamir K Gupta, Marlene Smurzynski, Nora Franceschini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 15, 2014
Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsRobert C Kalayjian, Kunling Wu, Scott Evans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 3, 2019
Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated IndividualsRobert C Kalayjian, Kevin R Robertson, Jeffrey M Albert, et al.
Pageof 6